Genmab A/S
NASDAQ:GMAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genmab A/S
NASDAQ:GMAB
|
DK |
|
C
|
Chow Tai Fook Jewellery Group Ltd
XMUN:1CT
|
HK |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
F:MUV2
|
DE |
|
U
|
Unite Group PLC
OTC:UTGPF
|
UK |
|
SRT Marine Systems PLC
LSE:SRT
|
UK |
|
Elbit Systems Ltd
F:EB2
|
IL |
|
C
|
Coca-Cola Consolidated Inc
F:CC5
|
US |
|
Bapcor Ltd
F:0BS
|
AU |
Wall St Price Targets
GMAB Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for GMAB is 34.44 USD with a low forecast of 19.88 USD and a high forecast of 47.69 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GMAB's stock price target?
Price Target
34.44
USD
According to Wall Street analysts, the average 1-year price target for GMAB is 34.44 USD with a low forecast of 19.88 USD and a high forecast of 47.69 USD.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
16%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 16%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.
